A PROMISE FOR A HEALTHIER TOMORROW

Cardiovascular & Vascular Products

Bisotensin
A well established combination indicated for the treatment of mild to moderate arterial hypertension. Its efficacy and safety have been extensively demonstrated in clinical trials and post-marketing use.
Combivasc
An ideal combination treatment of hypertension in patients not adequately controlled on monotherapy with either agent
Felovasc
A highly effective antihypertensive drug shows signi?cant reduction of elevated blood pressure with no negative inotropic e?ects with a subsequent lowering the risk of fatal or nonfatal cardiovascular events.